CA125-producing Clear Cell Adenocarcinoma Arising From the Upper Ureter and Renal Pelvis  by Shih, Chi-Min et al.
J Chin Med Assoc • January 2010 • Vol 73 • No 140
© 2010 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
Introduction
Clear cell adenocarcinoma of the female genital tract
has been well known in association with prebirth expo-
sure to diethylstilbestrol since 1971.1 Clear cell adeno-
carcinoma is thought to originate from the Müllerian
embryonal system.1 Clear cell adenocarcinomas occur
most often in the vagina, uterine cervix, endometrium
and ovary. In the urinary system, similar tumors have
been reported in the urethra, and urinary bladder
with a female predominance.2–4 Clear cell adenocarci-
nomas arising in the upper urinary tract are extremely
rare. We present an unusual case of cancer antigen
(CA) 125-producing clear cell adenocarcinoma aris-
ing in the ureter and renal pelvis of a patient with a
ureteral stone.
Case Report
A 73-year-old woman who had left flank pain for 3
months and a palpable mass over her left-side abdomen
was admitted. Microhematuria and mild hypochromatic
anemia were noted. High serum levels of CA125
(103.80U/mL; normal range, <35U/mL) and CA19-9
(151.96 U/mL; normal range, < 37 U/mL) were also
noted, whereas the serum level of carcinoembryonic
antigen (CEA) was within the normal range.
Intravenous pyelography, sonography and computed
tomography demonstrated left renal and ureteral stones
with severe hydronephrosis measuring up to 18 × 11 ×
9 cm in renal size. No tumor mass could be detected
anywhere including in the female genital tract using
any of the imaging techniques above. The patient under-
went nephrectomy and upper ureterectomy. Pathologic
examination of the resected specimen revealed 2 stones,
1 measuring up to 2.0 × 1.5 × 0.7 cm in the renal pelvis
and another spindle one measuring 1.5 × 0.7 × 0.6 cm
impacted in the ureter just distal to the ureteropelvic
junction. When the impacted ureteral stone was re-
moved, an annular papillary tumor measuring 1.5 cm
was found over the upper ureter, just distal to the
stone (Figure 1). Microscopically, the superficial por-
tion revealed papillary growth lined with a single layer
CASE REPORT
CA125-producing Clear Cell Adenocarcinoma
Arising From the Upper Ureter and Renal Pelvis
Chi-Min Shih1, Chuan-Te Huang2, Ching-Huang Chi3, Jui-Wei Lin4, Chin-Chen Pan5,6*
1Department of Anatomical Pathology, 2Division of Urology, and 3Department of Radiology, St. Joseph’s Hospital, 
Yunlin, 4Department of Pathology, Chang-Gung Memorial Hospital, Kaohsiung, 5Department of Pathology, 
Taipei Veterans General Hospital, and 6National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
Clear cell adenocarcinomas similar to those found in the female genital organs can arise in the lower urinary tract of
both women and men. Clear cell adenocarcinomas occurring in the upper urinary system are exceedingly rare. Here, we
present a case of clear cell adenocarcinoma arising from the upper ureter and renal pelvis of a postmenopausal woman
with a ureteral stone. The patient had elevated serum levels of cancer antigen (CA) 125 (103.80 U/mL) and CA19-9
(151.96 U/mL). The tumor showed typical features of tubulopapillary structures lined with clear-to-eosinophilic cytoplasm
and frequent hobnail configuration. The tumor cells were immunoreactive for cytokeratin 7, cytokeratin 20, carcinoembry-
onic antigen and CA125, but negative for PAX-2 and α-methylacyl coenzyme A racemase. Given the presence of intestinal
and squamous metaplasia of the adjacent urothelium, we propose that this clear cell adenocarcinoma developed
through a metaplastic process. The tumor behaved so aggressively that the patient developed multiple metastases and
died of the disease 5 months after radical nephroureterectomy. [J Chin Med Assoc 2010;73(1):40–43]
Key Words: CA125, CA19-9, clear cell adenocarcinoma, upper urinary tract
*Correspondence to: Dr Chin-Chen Pan, Department of Pathology, Taipei Veterans General Hospital,
201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.
E-mail: ccpan@vghtpe.gov.tw ● Received: February 13, 2009 ● Accepted: November 2, 2009
J Chin Med Assoc • January 2010 • Vol 73 • No 1 41
Clear cell adenocarcinoma of the upper urinary tract
of cuboidal cells, while the invasive portion consisted
chiefly of tubulocystic structures (Figure 2A) with
eosinophilic cytoplasm and frequent hobnail configu-
ration (Figure 2B). A second component consisting of
clear cells in a nesting pattern was present (Figure 2C).
The tumor infiltrated the underlying smooth muscle
wall of the ureter, nearby pelvic wall, and renal cortex
(Figure 2D). Moderate nuclear atypia and occasional
large nucleoli were observed. The stroma was desmo-
plastic and focally myxoid. The tumor cells were focally
positive for periodic acid-Schiff and mucicarmine, and
immunoreactive for cytokeratin 7 indicating a urothe-
lial origin, cytokeratin 20 proving its enteric metapla-
sia, CEA proving its adenocarcinomatous nature, and
CA125 indicating its relationship to high CA125
serum level and clear cell adenocarcinoma differentia-
tion (Figure 3). The tumor was immunohistochemi-
cally nonreactive for vimentin which ruled out renal
Figure 1. An impacted ureteral stone just distal to the left
ureteropelvic junction, and a 1.5-cm segment of annular villous
tumor over the distal ureter contiguous to the ureteral stone.
A B
C D
Figure 2. (A) The superficial portion of the tumor revealed papillary growth lined with a single layer of cuboidal cells, while the invasive
portion (arrowheads) consisted chiefly of tubulocystic structures (hematoxylin & eosin, 100×). (B) The tumor cells had eosinophilic cyto-
plasm with frequent hobnail configuration (arrows), and moderate nuclear atypia as well as occasional large nucleoli were observed
(hematoxylin & eosin, 400×). (C) A second component consisting of clear cells in a nesting pattern was present (hematoxylin & eosin,
200×). (D) The tubulocystic tumor (arrows) diffusely infiltrated the hydronephrotic cortex (hematoxylin & eosin, 20×).
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cell carcinoma, PAX-2 which excluded renal tubule
derived tumor, and α-methylacyl coenzyme A race-
mase which excluded papillary renal cell carcinoma.5
The histomorphology and immunoprofile were typi-
cally consistent with those of clear cell adenocarci-
noma. The adjacent urothelium exhibited squamous
and intestinal metaplasia.
The patient did not receive adjuvant therapy because
of her age and financial situation. Unfortunately, mul-
tiple pulmonary metastases were detected and she died
of the disease 5 months later.
Discussion
Although clear cell adenocarcinomas resembling those
in the female genital organs can occur in the lower
urinary tract,2–4,6–10 such tumors are extremely rare in
the upper urinary system. Reviewing the medical lit-
erature, only 2 cases have been reported in the renal
pelvis and ureter under a diagnosis of “papillary ade-
nocarcinoma” without specifying the histologic sub-
type.11,12 One of them was positive for CEA and
CA19-911 and the other was also positive for CA125.12
Another ureteral tumor simply diagnosed as “adeno-
carcinoma” was reported to produce CA19-9.13 To
our knowledge, there has not been a case specifically
reported as clear cell adenocarcinoma in this anatomic
location.
The tumor should be differentiated from other
variants of glandular lesions of urothelial and renal
cortical neoplasms. It is well known that urothelial
carcinoma is capable of a wide range of divergent dif-
ferentiation. Among the glandular types, the “not
otherwise specified” and enteric types are the most
common. Less frequent forms include mucinous,14
signet ring and villous tumors.15,16 These variants could
be differentiated from ours by their distinctive histo-
logic pattern. The tubulopapillary architecture and
clear to granular cells with hobnail appearance are
characteristic of clear cell adenocarcinoma. Our case
lacked the conventional portion of urothelial carcinoma.
The diagnosis is further supported by the high serum
levels of CA125 and CA19-9, as well as the immuno-
staining of CA125 in the tumor cells except for the
clear cell pattern. In addition, the tumor is unlikely to
represent renal cell carcinoma. Clear cell renal cell car-
cinoma exhibits clear or granular cytoplasm, and both
papillary renal cell carcinoma and collecting duct car-
cinoma may reveal tubulopapillary pattern. However,
they have the immunoreactivity for α-methylacyl coen-
zyme A racemase, and never show hobnail configuration
as clear cell adenocarcinoma does.
Another major differential consideration is neph-
rogenic adenoma. Clear cell adenocarcinoma, when
well differentiated, may closely resemble nephrogenic
adenoma.17 However, the presence of nuclear atypia,
enlarged nucleoli, and invasive growth are incompati-
ble with nephrogenic adenoma. Clinically, the tumor
also behaved aggressively in contrast to the benign
nature of nephrogenic adenoma. There has been 1
report providing molecular evidence suggesting the
progression from nephrogenic adenoma to clear cell
adenocarcinoma.10 Immunohistochemically, PAX-2
and α-methylacyl coenzyme A racemase, which are
usually positive in nephrogenic adenoma,18,19 were
negative in this case.
There have been several hypotheses regarding the
histogenesis of clear cell adenocarcinoma in the urinary
system. Recently, the tumor has either been considered
to be malignant transformation of tissue originating
from an aberrant Müllerian duct or to be of metaplas-
tic origin from urothelium. Aberrant Müllerian tissue
is unlikely to be found in the renal pelvis. On the other
hand, since this clear cell adenocarcinoma was closely
related to an impacted stone of the upper ureter and
superficially contiguous with metaplastic squamous and
intestinal type epithelium, the hypothesis of metaplasia
is more plausible.
Finally, the possibility of clear cell adenocarcinoma
from the female genital tract or reactive peritonitis
inducing high CA125 serum level can be excluded by
thorough clinical studies and immunostaining of CA125
in the tumor cells. The coexistence of superficial and
contiguous deep parts, and the relationship of the super-
ficial tumor with adjacent ureterorenal stones indicate
a primary tumor rather than a metastatic tumor from
Figure 3. CA125 immunostaining reveals positive staining in the
papillary portion (not shown) and tubular invading portion, but
nearly negative staining in the tumor cells with clear cytoplasm
(CA125, 400×).
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other sites. Unfortunately, the postoperative reduc-
tion of the serum level of CA125 and CA19-9 was
not checked to further confirm their relationship with
this clear cell adenocarcinoma of the upper urinary
tract.
In conclusion, we have demonstrated a primary
clear cell adenocarcinoma occurring in the renal pelvis
and upper ureter. Although it is rare, a tumor can
develop in the upper urinary system, probably origina-
ting from a malignant transformation of metaplastic
urothelium. High levels of CA125 and CA19-9 in
serum might serve as markers of clear cell adenocarci-
noma in organs other than the female genital organs,
and as useful indicators during follow-up to determine
whether the tumor has been eradicated or to look out
for tumor recurrence.
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